Cold atmospheric plasma: a new modality to treat chronic diabetic foot ulcers, venous leg ulcers, and pressure ulcers
DOI:
https://doi.org/10.63676/5waqaz41Abstract
This study investigates the efficacy and safety of cold atmospheric plasma (CAP) in the treatment of 12 patients suffering from chronic wounds, focusing on diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), and pressure ulcers. Chronic wounds represent a significant challenge in healthcare, often taking months to years to heal and imposing a substantial economic and quality of life burden on patients. CAP, an ionized gas at room temperature, is a source of reactive species, neutral particles, electromagnetic fields, and weak UV radiation. Its interaction with human cells stimulates wound healing processes, including cytokine release and angiogenesis, while exerting a bactericidal effect on prokaryotic cells. On average the 12 subjects had a percentage area reduction (PAR) of 21%, within the VLU group 60% of the subjects achieved a >40% PAR, and in the DFU group, 50% of the participants achieved a >40% PAR. Despite promising evidence from various studies, more data is needed to establish CAP as a standard treatment. This study contributes to the existing knowledge by evaluating the safety and effectiveness of CAP in treating long-standing and treatment-resistant ulcers. The study utilized the plasma care® device, a compact medical device that generates CAP using ambient air and energy. The plasma care® has shown notable efficacy in deactivating various bacteria and fungi, irrespective of antibiotic resistance.
References
Nussbaum SR, Carter MJ, Fife CE, et al. An economic evaluation of the impact, cost, and Medicare policy implications of chronic nonhealing wounds. Value Health. 2018;21(1):27-32. https://doi.org/10.1016/j.jval.2017.07.007 DOI: https://doi.org/10.1016/j.jval.2017.07.007
Raghav A, Khan ZA, Labala RK, Ahmad J, Noor S, Mishra BK. Financial burden of diabetic foot ulcers to world: a progressive topic to discuss always. Ther Adv Endocrinol Metab. 2018;9(1):29-31. https://doi.org/10.1177/2042018817744513 DOI: https://doi.org/10.1177/2042018817744513
Abbade LP, Lastória S. Venous ulcer: epidemiology, physiopathology, diagnosis and treatment. Int J Dermatol. 2005;44(6):449-456. https://doi.org/10.1111/j.1365-4632.2004.02456.x DOI: https://doi.org/10.1111/j.1365-4632.2004.02456.x
Coleman S, Gorecki C, Nelson EA, et al. Patient risk factors for pressure ulcer development: systematic review. Int J Nurs Stud. 2013;50(7):974-1003. https://doi.org/10.1016/j.ijnurstu.2012.11.019 DOI: https://doi.org/10.1016/j.ijnurstu.2012.11.019
Edsberg LE, Black JM, Goldberg M, McNichol L, Moore L, Sieggreen M. Revised National Pressure Ulcer Advisory Panel Pressure Injury Staging System: Revised Pressure Injury Staging System. J Wound Ostomy Continence Nurs. 2016;43(6):585-597. https://doi.org/10.1097/WON.0000000000000281 DOI: https://doi.org/10.1097/WON.0000000000000281
Yan D, Xu W, Yao X, Lin L, Sherman JH, Keidar M. The Cell Activation Phenomena in the Cold Atmospheric Plasma Cancer Treatment. Sci Rep. 2018;8(1):15418. https://doi.org/10.1038/s41598-018-33914-w DOI: https://doi.org/10.1038/s41598-018-33914-w
Isbary G, Morfill G, Schmidt HU, et al. A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br J Dermatol. 2010;163(1):78-82. https://doi.org/10.1111/j.1365-2133.2010.09744.x DOI: https://doi.org/10.1111/j.1365-2133.2010.09744.x
Isbary G, Heinlin J, Shimizu T, et al. Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial. Br J Dermatol. 2012;167(2):404-410. https://doi.org/10.1111/j.1365-2133.2012.10923.x DOI: https://doi.org/10.1111/j.1365-2133.2012.10923.x
Isbary G, Stolz W, Shimizu T, et al. Cold atmospheric argon plasma treatment may accelerate wound healing in chronic wounds: results of an open retrospective randomized controlled study in vivo. Clin. Plasma Med. 2013, 1 (2), 25-30. https://doi.org/10.1016/j.cpme.2013.06.001 DOI: https://doi.org/10.1016/j.cpme.2013.06.001
Heinlin J, Zimmermann JL, Zeman F, et al. Randomized placebo-controlled human pilot study of cold atmospheric argon plasma on skin graft donor sites. Wound Repair Regen. 2013;21(6):800-807. https://doi.org/10.1111/wrr.12078 DOI: https://doi.org/10.1111/wrr.12078
Stratmann B, Costea TC, Nolte C, et al. Effect of cold atmospheric plasma therapy vs standard therapy placebo on wound healing in patients with diabetic foot ulcers: a randomized clinical trial. JAMA Netw Open. 2020;3(7):e2010411. https://doi.org/10.1001/jamanetworkopen.2020.10411 DOI: https://doi.org/10.1001/jamanetworkopen.2020.10411
Jensen JO, Schulz L, Schleusser S, et al. The repetitive application of cold atmospheric plasma (CAP) improves microcirculation parameters in chronic wounds. Microvasc Res. 2021;138:104220. https://doi.org/10.1016/j.mvr.2021.104220 DOI: https://doi.org/10.1016/j.mvr.2021.104220
Arjunan KP, Friedman G, Fridman A, Clyne AM. Non-thermal dielectric barrier discharge plasma induces angiogenesis through reactive oxygen species. J R Soc Interface. 2012;9(66):147-157. https://doi.org/10.1098/rsif.2011.0220 DOI: https://doi.org/10.1098/rsif.2011.0220
Arndt S, Landthaler M, Zimmermann JL, et al. Effects of cold atmospheric plasma (CAP) on ß-defensins, inflammatory cytokines, and apoptosis-related molecules in keratinocytes in vitro and in vivo. PLoS One. 2015;10(3):e0120041. https://doi.org/10.1371/journal.pone.0120041 DOI: https://doi.org/10.1371/journal.pone.0120041
Oropallo AR, Andersen C, Abdo R, et al. Guidelines for Point-of-Care Fluorescence Imaging for Detection of Wound Bacterial Burden Based on Delphi Consensus. Diagnostics (Basel). 2021;11(7):1219. https://doi.org/10.3390/diagnostics11071219 DOI: https://doi.org/10.3390/diagnostics11071219
Armstrong DG, Edmonds ME, Serena TE. Point-of-care fluorescence imaging reveals extent of bacterial load in diabetic foot ulcers. Int Wound J. 2023;20(2):554-566. https://doi.org/10.1111/iwj.14080 DOI: https://doi.org/10.1111/iwj.14080
Sheehan P, Jones P, Caselli A, Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care. 2003;26(6):1879-1882. https://doi.org/10.2337/diacare.26.6.1879 DOI: https://doi.org/10.2337/diacare.26.6.1879
Lavery LA, Barnes SA, Keith MS, Seaman JW Jr, Armstrong DG. Prediction of healing for postoperative diabetic foot wounds based on early wound area progression. Diabetes Care. 2008;31(1):26-29. https://doi.org/10.2337/dc07-1300 DOI: https://doi.org/10.2337/dc07-1300
Phillips TJ, Machado F, Trout R, Porter J, Olin J, Falanga V. Prognostic indicators in venous ulcers. J Am Acad Dermatol. 2000;43(4):627-630. https://doi.org/10.1067/mjd.2000.107496 DOI: https://doi.org/10.1067/mjd.2000.107496
Thomas DR, Goode PS, LaMaster K, Tennyson T. Acemannan hydrogel dressing versus saline dressing for pressure ulcers. A randomized, controlled trial. Adv Wound Care. 1998;11(6):273-276.
Armstrong DG, Lavery LA. Diabetic foot ulcers: prevention, diagnosis and classification. Am Fam Physician. 1998;57(6):1325-1338.
Published
Issue
Section
License
Copyright (c) 2025 International Journal of Tissue Repair
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
